Trevor Scheid
Director, MS Strategic Planning, Analytics, and Insights at TG Therapeutics, Inc. - New York, NY, US
Trevor Scheid's Colleagues at TG Therapeutics, Inc.
Trevor Scheid's Contact Details
HQ
(212) 554-4484
(212) 554-4484
Location
Company
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Trevor Scheid's Company Details
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Frequently Asked Questions about Trevor Scheid
Trevor Scheid currently works for TG Therapeutics, Inc..
Trevor Scheid's role at TG Therapeutics, Inc. is Director, MS Strategic Planning, Analytics, and Insights.
Trevor Scheid's email address is ***@tgtxinc.com. To view Trevor Scheid's full email address, please signup to ConnectPlex.
Trevor Scheid works in the BioTech/Drugs industry.
Trevor Scheid's colleagues at TG Therapeutics, Inc. are Sam Wilson, Joseph Tonda, Kathryn Bercury-Russell, Anita Joice, Michele Volk, Sharon MBA, Mark Zanders and others.
Trevor Scheid's phone number is (212) 554-4484